KELLY PRICE: Open Payments
NPI 1528640414 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,031 in 77 payments from 31 companies in 2025. Trend: 2023 $2,193 · 2024 $2,892 · 2025 $2,031
Food & beverage: $2,031
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 6 | $259 |
| UCB, Inc. | 8 | $252 |
| ABBVIE INC. | 8 | $152 |
| Lundbeck LLC | 5 | $118 |
| MDD US Operations, LLC | 1 | $97 |
| Tanabe Pharma America, Inc. | 3 | $78 |
| Neurocrine BioSciences, Inc. | 3 | $74 |
| Alexion Pharmaceuticals, Inc. | 3 | $69 |
| ARGENX US, INC. | 3 | $68 |
| Cycle Pharmaceuticals Inc | 3 | $68 |
Products named: Fintepla, VYEPTI, XCOPRI, Gocovri, Radicava, INGREZZA, UBRELVY, ULTOMIRIS.
Industry payments across VA — which companies pay providers there.
